Director's message

Statement from the Director

The Unit was established in 1988 to improve the understanding and control of the HIV epidemic in Uganda and globally, following a request from the Uganda Government to the United Kingdom (UK) Government. On 1st February, 2018, the MRC/UVRI Uganda Research Unit formally joined the London School of Hygiene and Tropical Medicine (LSHTM) and became The MRC/UVRI and LSHTM Uganda Research Unit. The partnership that will boost research capacity into some of the current and emerging health issues in Africa and the world.

To build on our work in HIV, the Unit broadened its work to include other neglected, endemic, emerging and re-emerging infections; as well as Non-communicable diseases (NCDs). Currently, the Unit conducts its research under three Themes, namely: HIV and Emerging infections; Vaccines and Immunity and Chronic diseases and Cancer. While Themes address cross cutting research questions, the implementation is based on a multi-disciplinary approach through six Programmes below.

1) HIV Epidemiology and Intervention Programme (HIV), 2) Non-communicable diseases Programme (NCD), 3) Pathogen Genomics, Phenotype and Immunity Programme (PGPI), 4) Social Aspects of Health Across the Life Course Programme (SOC), 5) Immunomodulation and Vaccine Programme (I-Vac) and 6) Cancer Epidemiology Programme. 

Using our multidisciplinary approach, the Unit, with support from our partners, has been at the forefront of responding to the COVID-19 pandemic in the country.



Pontiano Kaleebu
Professor Pontiano Kaleebu
Director MRC/UVRI and LSHTM Uganda Research Unit